Cellectis (CLLS) Other Non-Current Assets (2014 - 2026)
Cellectis' (CLLS) quarterly Other Non-Current Assets came in at $21.3 million in Q1 2026, up 58.34% year-on-year from $13.4 million in Q1 2025, and up 6.3% quarter-over-quarter from $20.0 million in Q4 2025.
Cellectis (CLLS) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Cellectis' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $21.3 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 58.34% year-over-year to $21.3 million in Q1 2026; TTM through Mar 2026 was $21.3 million, a 58.34% increase from a year earlier, with the FY2025 full-year figure at $20.0 million, up 72.72% from the prior year.
- Other Non-Current Assets rose to $21.3 million in Q1 2026 per CLLS's latest filing, from $20.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $21.3 million in Q1 2026 and bottomed at $175000.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $13.4 million (2025), against an average of $13.5 million.
- Across the five-year window, Other Non-Current Assets tumbled 99.21% in 2022 and surged 11405.71% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $8.8 million in 2022, then decreased by 10.67% to $7.9 million in 2023, then soared by 47.64% to $11.6 million in 2024, then jumped by 72.72% to $20.0 million in 2025, then advanced by 6.3% to $21.3 million in 2026.
- Per Business Quant, the three latest CLLS Other Non-Current Assets figures stand at $21.3 million (Q1 2026), $20.0 million (Q4 2025), and $18.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 21.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.29 Mn |
| Dec 31, 2025 | 20.03 Mn |
| Sep 30, 2025 | 18.18 Mn |
| Jun 30, 2025 | 16.13 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Dec 31, 2024 | 11.59 Mn |
| Sep 30, 2024 | 11.12 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Mar 31, 2023 | 20.14 Mn |
| Dec 31, 2022 | 8.79 Mn |
| Mar 31, 2022 | 175,000.00 |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 22.05 Mn |
| Jun 30, 2021 | 22.10 Mn |
| Mar 31, 2021 | 22.11 Mn |
| Dec 31, 2020 | 7.01 Mn |
| Sep 30, 2020 | 9.78 Mn |
| Jun 30, 2020 | 7.38 Mn |
| Mar 31, 2020 | 7.48 Mn |
| Dec 31, 2019 | 5.52 Mn |